DK0826370T3 - Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom - Google Patents

Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom

Info

Publication number
DK0826370T3
DK0826370T3 DK97104503T DK97104503T DK0826370T3 DK 0826370 T3 DK0826370 T3 DK 0826370T3 DK 97104503 T DK97104503 T DK 97104503T DK 97104503 T DK97104503 T DK 97104503T DK 0826370 T3 DK0826370 T3 DK 0826370T3
Authority
DK
Denmark
Prior art keywords
alzheimer
phenyl
treatment
benzisoselenazol
disease
Prior art date
Application number
DK97104503T
Other languages
Danish (da)
English (en)
Inventor
Hiroyuko Masayasu
Ikuro Maruyama
Kazuhiro Abeyama
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of DK0826370T3 publication Critical patent/DK0826370T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97104503T 1996-08-27 1997-03-17 Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom DK0826370T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27

Publications (1)

Publication Number Publication Date
DK0826370T3 true DK0826370T3 (da) 2002-10-07

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97104503T DK0826370T3 (da) 1996-08-27 1997-03-17 Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom

Country Status (29)

Country Link
US (1) US5948800A (cs)
EP (1) EP0826370B1 (cs)
KR (1) KR20000035859A (cs)
CN (1) CN1112922C (cs)
AT (1) ATE219361T1 (cs)
AU (2) AU3866997A (cs)
BR (1) BR9711259A (cs)
CA (1) CA2213794C (cs)
CZ (1) CZ295364B6 (cs)
DE (2) DE59707550D1 (cs)
DK (1) DK0826370T3 (cs)
EE (1) EE03953B1 (cs)
ES (1) ES2177849T3 (cs)
FI (1) FI119622B (cs)
HK (1) HK1020317A1 (cs)
HU (1) HU225264B1 (cs)
IL (1) IL127113A (cs)
LT (1) LT4602B (cs)
LV (1) LV12251B (cs)
NO (1) NO312812B1 (cs)
NZ (1) NZ332292A (cs)
PL (1) PL188481B1 (cs)
PT (1) PT826370E (cs)
SI (1) SI9720060B (cs)
TR (1) TR199700858A2 (cs)
TW (1) TW501925B (cs)
UA (1) UA59367C2 (cs)
WO (2) WO1998008511A1 (cs)
ZA (1) ZA977644B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0729756T3 (da) * 1993-10-27 2000-06-05 Daiichi Seiyaku Co Granulært farmaceutisk præparat
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
HK1020317A1 (en) 2000-04-14
UA59367C2 (uk) 2003-09-15
CN1112922C (zh) 2003-07-02
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
FI982689A0 (fi) 1998-12-11
NO973912L (no) 1998-03-02
SI9720060B (en) 2001-12-31
ZA977644B (en) 1999-02-26
TW501925B (en) 2002-09-11
LV12251B (lv) 1999-08-20
HUP9903213A1 (en) 2000-07-28
KR20000035859A (ko) 2000-06-26
FI982689A (fi) 1998-12-11
PT826370E (pt) 2002-10-31
EE9900007A (et) 1999-06-15
ATE219361T1 (de) 2002-07-15
PL321796A1 (en) 1998-03-02
BR9711259A (pt) 1999-08-17
US5948800A (en) 1999-09-07
HU225264B1 (en) 2006-08-28
LT4602B (lt) 2000-01-25
CZ295364B6 (cs) 2005-07-13
TR199700858A2 (xx) 1998-03-21
PL188481B1 (pl) 2005-02-28
NO973912D0 (no) 1997-08-26
DE59707550D1 (de) 2002-07-25
SI9720060A (sl) 1999-06-30
FI119622B (fi) 2009-01-30
AU3866997A (en) 1998-03-19
IL127113A0 (en) 1999-09-22
CZ31799A3 (cs) 1999-11-17
WO1998008831A1 (fr) 1998-03-05
IL127113A (en) 2003-07-06
AU725534B2 (en) 2000-10-12
EP0826370A1 (de) 1998-03-04
CA2213794A1 (en) 1998-02-27
EP0826370B1 (de) 2002-06-19
CA2213794C (en) 2006-10-03
NZ332292A (en) 2001-07-27
CN1223580A (zh) 1999-07-21
WO1998008511A1 (de) 1998-03-05
ES2177849T3 (es) 2002-12-16
LT99016A (en) 1999-10-25
LV12251A (lv) 1999-04-20
DE19733690A1 (de) 1998-03-26
NO312812B1 (no) 2002-07-08
EE03953B1 (et) 2003-02-17

Similar Documents

Publication Publication Date Title
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK0826370T3 (da) Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom
FI934223A (fi) Heterocykliscykliska aminderivat
HUP0002742A2 (hu) Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
DK1007040T3 (da) Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom
DK0590321T3 (da) Anvendelse af NADH og NADPH til fremstilling af et lægemiddel til behandling af Alzheimers sygdom
EP0345247A3 (de) Verwendung von monosubstituierten selenorganischen Verbindungen zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
HUP9701060A2 (hu) Darifenacint tartalmazó gyógyszerkészítmény kognitív zavarok kezelésére
DE69008466D1 (de) Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
NO953072L (no) Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
AU5255501A (en) Choline derivatives for the treatment of alzheimer's disease
DK1152762T3 (da) Anvendelse af desoxypeganin til behandling af Alzheimers demens
NO930083D0 (no) Sammensetning for behandling av alzheimers sykdom og fremgangsmaate for fremstilling
GEP20002141B (en) Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease